Chaetocin induces caspase‑dependent apoptosis in ovarian cancer cells via the generation of reactive oxygen species

Li,Zhongjun; Huang,Lishan; Wei,Li; Hou,Zhiyong; Ye,Weibiao; Huang,Suran

doi:10.3892/ol.2019.10507

Chaetocin induces caspase‑dependent apoptosis in ovarian cancer cells via the generation of reactive oxygen species

Authors:
- Zhongjun Li
- Lishan Huang
- Li Wei
- Zhiyong Hou
- Weibiao Ye
- Suran Huang
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Dongguan Affiliated Hospital of Southern Medical University, Dongguan, Guangdong 523059, P.R. China, Department of Pathology, Dongguan Affiliated Hospital of Southern Medical University, Dongguan, Guangdong 523059, P.R. China
Published online on: June 21, 2019 https://doi.org/10.3892/ol.2019.10507
Pages: 1915-1921
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian cancer (OC) is one of the most common types of cancer among women worldwide. The majority of patients with OC respond to current chemotherapy approaches initially; however, patients are likely to experience cancer recurrence and become resistant to the chemotherapy. Therefore, novel agents for the treatment of OC are urgently required. Chaetocin, a natural product isolated from Chaetomium fungi, has been reported to exhibit anticancer activity against various types of cancer; however, the pharmacological action and detailed mechanism underlying the effects of chaetocin on OC cells remain unclear. Therefore, the present study investigated the cytotoxic effects of chaetocin on OC cells. A Cell Counting kit‑8 assay was used to study cell viability, a colony formation assay was used to assess cell proliferation, flow cytometry was used to detect apoptosis, cell cycle and reactive oxygen species (ROS) generation, and western blotting was used to determine the protein levels of poly (ADP‑ribose) polymerase, caspase‑3 and cleaved‑caspase‑3. The results demonstrated that chaetocin significantly decreased the viability of OC cells. Chaetocin inhibited the proliferation and induced G2/M phase arrest of the OVCAR‑3 OC cell line. Additionally, chaetocin induced apoptotic cell death in OVCAR‑3 cells via the caspase pathway. It was observed that chaetocin induced the accumulation of ROS in OVCAR‑3 cells. Treatment with the ROS scavenger N‑acetyl‑L‑cysteine reversed the apoptotic effects and activation of the caspase pathway induced by chaetocin. Collectively, these results revealed that chaetocin suppressed the proliferation and promoted the caspase‑dependent apoptosis of OC cells by increasing the levels of ROS. Therefore, chaetocin may serve as a potential therapeutic agent for the treatment of OC.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Gamarra-Luques CD, Hapon MB, Goyeneche AA and Telleria CM: Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity. J Ovarian Res. 7:452014. View Article : Google Scholar : PubMed/NCBI
3	Cho KR and Shih IeM: Ovarian cancer. Annu Rev Pathol. 4:287–313. 2009. View Article : Google Scholar : PubMed/NCBI
4	Sekita S, Yoshihira K, Natori S, Udagawa S, Muroi T, Sugiyama Y, Kurata H and Umeda M: Mycotoxin production by Chaetomium spp. and related fungi. Can J Microbiol. 27:766–772. 1981. View Article : Google Scholar : PubMed/NCBI
5	Hauser D, Weber HP and Sigg HP: Isolation and configuration of Chaetocin. Helv Chim Acta. 53:1061–1073. 1970.(In German). View Article : Google Scholar : PubMed/NCBI
6	Liu X, Guo S, Liu X and Su L: Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells. Apoptosis. 20:1499–1507. 2015. View Article : Google Scholar : PubMed/NCBI
7	Isham CR, Tibodeau JD, Jin W, Xu R, Timm MM and Bible KC: Chaetocin: A promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress. Blood. 109:2579–2588. 2007. View Article : Google Scholar : PubMed/NCBI
8	Lai YS, Chen JY, Tsai HJ, Chen TY and Hung WC: The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells. Blood Cancer J. 5:e3132015. View Article : Google Scholar : PubMed/NCBI
9	Isham CR, Tibodeau JD, Bossou AR, Merchan JR and Bible KC: The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation. Br J Cancer. 106:314–323. 2012. View Article : Google Scholar : PubMed/NCBI
10	Dixit D, Ghildiyal R, Anto NP and Sen E: Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. Cell Death Dis. 5:e12122014. View Article : Google Scholar : PubMed/NCBI
11	Lee YM, Lim JH, Yoon H, Chun YS and Park JW: Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1α pre-mRNA in mice and in vitro. Hepatology. 53:171–180. 2011. View Article : Google Scholar : PubMed/NCBI
12	Chaib H, Nebbioso A, Prebet T, Castellano R, Garbit S, Restouin A, Vey N, Altucci L and Collette Y: Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. Leukemia. 26:662–674. 2012. View Article : Google Scholar : PubMed/NCBI
13	Truitt L, Hutchinson C, DeCoteau JF and Geyer CR: Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance. Oncogenesis. 3:e1222014. View Article : Google Scholar : PubMed/NCBI
14	Vo MC, Nguyen-Pham TN, Lee HJ, Jung SH, Choi NR, Hoang MD, Kim HJ and Lee JJ: Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells. Oncotarget. 8:46047–46056. 2017. View Article : Google Scholar : PubMed/NCBI
15	Han X, Han Y, Zheng Y, Sun Q, Ma T, Zhang J and Xu L: Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo. PLoS One. 12:e1759502017.
16	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
17	Coleman RL, Monk BJ, Sood AK and Herzog TJ: Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 10:211–224. 2013. View Article : Google Scholar : PubMed/NCBI
18	Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI
19	Cotter TG: Apoptosis and cancer: The genesis of a research field. Nat Rev Cancer. 9:501–507. 2009. View Article : Google Scholar : PubMed/NCBI
20	Ferrin G, Linares CI and Muntané J: Mitochondrial drug targets in cell death and cancer. Curr Pharm Des. 17:2002–2016. 2011. View Article : Google Scholar : PubMed/NCBI
21	Dong Y, Cao A, Shi J, Yin P, Wang L, Ji G, Xie J and Wu D: Tangeretin, a citrus polymethoxyflavonoid, induces apoptosis of human gastric cancer AGS cells through extrinsic and intrinsic signaling pathways. Oncol Rep. 31:1788–1794. 2014. View Article : Google Scholar : PubMed/NCBI
22	Roy J, Galano JM, Durand T, Le Guennec JY and Lee JC: Physiological role of reactive oxygen species as promoters of natural defenses. FASEB J. 31:3729–3745. 2017. View Article : Google Scholar : PubMed/NCBI
23	Holmström KM and Finkel T: Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 15:411–421. 2014. View Article : Google Scholar : PubMed/NCBI
24	D'Autréaux B and Toledano MB: ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 8:813–824. 2007. View Article : Google Scholar : PubMed/NCBI
25	Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB: Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI
26	Galadari S, Rahman A, Pallichankandy S and Thayyullathil F: Reactive oxygen species and cancer paradox: To promote or to suppress? Free Radic Biol Med. 104:144–164. 2017. View Article : Google Scholar : PubMed/NCBI
27	Weng MS, Chang JH, Hung WY, Yang YC and Chien MH: The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance. J Exp Clin Cancer Res. 37:612018. View Article : Google Scholar : PubMed/NCBI
28	Tafani M, Sansone L, Limana F, Arcangeli T, De Santis E, Polese M, Fini M and Russo MA: The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression. Oxid Med Cell Longev. 2016:39071472016. View Article : Google Scholar : PubMed/NCBI
29	Zou P, Xia Y, Ji J, Chen W, Zhang J, Chen X, Rajamanickam V, Chen G, Wang Z, Chen L, et al: Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Cancer Lett. 375:114–126. 2016. View Article : Google Scholar : PubMed/NCBI
30	Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, et al: Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 475:231–234. 2011. View Article : Google Scholar : PubMed/NCBI
31	He J, Chen X, Li B, Zhou W, Xiao J, He K, Zhang J and Xiang G: Chaetocin induces cell cycle arrest and apoptosis by regulating the ROS-mediated ASK-1/JNK signaling pathways. Oncol Rep. 38:2489–2497. 2017. View Article : Google Scholar : PubMed/NCBI